Table 3.
Medical history of enrolled patients with evaluable total testosterone
| Condition | Hypogonadal patients (n = 836) | Eugonadal patients (n = 1326) | p-value* |
|---|---|---|---|
| Hypertension | 547 (65.4) | 678 (51.1) | <0.001 |
| Hyperlipidaemia | 506 (60.5) | 670 (50.5) | <0.001 |
| Diabetes | 258 (30.9) | 237 (17.9) | <0.001 |
| Obesity | 270 (32.3) | 225 (17.0) | <0.001 |
| Prostatic disease/disorder | 165 (19.7) | 226 (17.0) | 0.121 |
| Chronic pain | 155 (18.5) | 211 (16.0) | 0.113 |
| Insomnia/sleep disturbance | 129 (15.4) | 185 (14.0) | 0.342 |
| Asthma/COPD | 102 (12.2) | 118 (8.9) | 0.013 |
| Headaches (within the last 2 weeks) | 70 (8.4) | 125 (9.4) | 0.405 |
| Rheumatoid arthritis | 28 (3.3) | 29 (2.2) | 0.101 |
| Osteoporosis | 15 (1.8) | 15 (1.1) | 0.199 |
| Not reported | 0 (0.0) | 4 (0.3) | nr |
Values are expressed as n (%). COPD, chronic obstructive pulmonary disease; nr, statistical test not conducted.
*
p-values obtained from chi-square test of hypogonadal vs. eugonadal patients.